Imatinib Mesylate and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Myelogenous Leukemia
Clinical trial NCT00066326 · COMPLETED
Trial details
- NCT number
- NCT00066326
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2003-06-01
- Primary completion
- 2004-10-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.